Market Place
Sourcing Support
Northwest Biotherapeutics Reports Positive Annual Meeting Votes And Progress
03 Jul 2024 //
PR NEWSWIRE
NW Bio In-Licenses Dendritic Cell Tech And IP Portfolio
18 Jun 2024 //
PHARMABIZ
Northwest Announces That A MAA Has Been Submitted To MHRA For DCVax®-L
21 Dec 2023 //
PR NEWSWIRE
Northwest Biotherapeutics Provides Update On Final Preparations For MAA
22 Nov 2023 //
PR NEWSWIRE
Northwest Provides Update On Near Term Plans For Submission of MAA
13 Oct 2023 //
PR NEWSWIRE
Northwest Announces That Dr. Linda Liau Has Joined Scientific Advisory Board
12 Sep 2023 //
PR NEWSWIRE
Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans
29 Aug 2023 //
PR NEWSWIRE
Northwest Bio, Advent BioServices Gain MHRA License for Commercial Manufacturing
24 Mar 2023 //
CONTRACT PHARMA
Northwest and Advent Announce License for Commercial Manufacturing at Sawston
20 Mar 2023 //
PR NEWSWIRE
Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB
11 Mar 2023 //
PR NEWSWIRE
Northwest Reports Positive Top-Line Results From Phase 3 Trial of DCVax-L
17 Nov 2022 //
PRNEWSWIRE
Paediatric Investigation Plan approved by MHRA
24 Aug 2022 //
PHARMAFILE
Northwest Bio to File Application for License for Commercial Manufacturing
06 Jul 2022 //
PRNEWSWIRE
Northwest Biotherapeutics to Present On DCVax-L Personalized Vaccines
05 Jun 2022 //
PRNEWSWIRE
Northwest Biotherapeutics Receives MHRA Approval of License for GMP Mfg in UK
22 Dec 2021 //
CONTRACTPHARMA
Northwest Bio Announces MHRA Approval Of License for GMP Manufacturing
21 Dec 2021 //
PRNEWSWIRE
Northwest Biotherapeutics Announces HTA License Issued and MHRA Inspection
28 Oct 2021 //
PRESS RELEASE
UK Manufacturing Facility & PhIII Trial Updates From Northwest Biotherapeutics
12 May 2021 //
PRNEWSWIRE
UK Manufac Facility & Phase III Trial Updates From Northwest Biotherapeutics
11 May 2021 //
PRNEWSWIRE
Northwest Biotherapeutics Adds Production Capacity at UK Facility
16 Mar 2021 //
CONTRACTPHARMA
Northwest Biotherapeutics Announces Data Lock of Phase III Trial
05 Oct 2020 //
PRNEWSWIRE
Northwest Biotherapeutics Acquires Flaskworks
01 Sep 2020 //
PRNEWSWIRE
Northwest Biotherapeutics Announces Completion of Phase 3 Trial Sites` Databases
24 Jul 2020 //
PRNEWSWIRE
NW Bio Provides Update On Projected Timing For Data Lock For Ph3 Trial of DCVax®
02 Jun 2020 //
NWBIO
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.